The centre is set to introduce the Drugs, Medical Devices and Cosmetics Bill, 2023. The cosmetic business eagerly awaits the impact of this bill on the industry. is eagerly awaited by the cosmetics business. This legislation will replace the outdated Drugs and Cosmetics Act, 1940. It holds the promise of aligning our industry with global standards.
Gujarat industry contributes a substantial 30% nationally and this law will be instrumental in bringing international regulatory practices to the forefront. It will elevate not only businesses but the entire Indian pharma, cosmetics and medical device sector. The comprehensive coverage of critical areas like medical devices and clinical trials within a legal framework is particularly encouraging.
AWAITED CHANGES
Active involvement in consultations with Gujarat’s drug controllers and industry associations reveals plans for the establishment of key advisory boards – the Drugs Technical Advisory Board (DTAB) and the Medical Devices Technical Advisory Board (MDTAB). The emphasis on the manufacturer’s authority to recall products, including cosmetics, underscores a positive step towards enhancing safety for consumers.
The central government takes charge of regulating the import aspects, including cosmetics, and the states overseeing sales and distribution. This legislation will streamline operations. Enactment of the law not only promises ease of doing business but also aids in the decriminalization of minor offences. It aligns the cosmetic and pharma industry with global quality standards and supports the vision of Atmanirbhar Bharat.
EFFECTS
The bill is a key driver for ensuring the quality, safety, and efficacy of products. It welcomes the establishment of regulatory frameworks such as Good Manufacturing Practices (GMP) and Good Distribution Practices (GDP). It aims to enhance the quality of our cosmetic products throughout the supply chain.
Crucially, the bill introduces provisions for emergency use approval, accelerated approval for new cosmetic products, and guidelines for compensation in cases of consumer issues. This forward-looking legislation also includes a risk-based classification for cosmetic devices. It addresses the powers and regulations regarding the online sale of cosmetics. Overall, this comprehensive legislation marks a significant leap forward for the Indian cosmetics industry.
Courtesy Link: https://www.vibesofindia.com/centre-may-table-drugs-and-cosmetics-bill-2023-in-parl-session/